Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
An imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response of the tumor-bearing host. We previously reported the profiles of tumor infiltrating leukocytes in cutaneous angiosarcoma (AS) and suggested that a combination of docetaxel...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/325412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555403812012032 |
|---|---|
| author | Taku Fujimura Yumi Kambayashi Sadanori Furudate Aya Kakizaki Setsuya Aiba |
| author_facet | Taku Fujimura Yumi Kambayashi Sadanori Furudate Aya Kakizaki Setsuya Aiba |
| author_sort | Taku Fujimura |
| collection | DOAJ |
| description | An imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response of the tumor-bearing host. We previously reported the profiles of tumor infiltrating leukocytes in cutaneous angiosarcoma (AS) and suggested that a combination of docetaxel (DTX) with bisphosphonate risedronate sodium (RS) might be effective for MMP9-expressing AS by targeting immunosuppressive cells such as M2 macrophages. To further confirm the effect of this combination therapy, in this report we investigated the immunomodulatory effect of DTX and RS on CD163+ arginase 1 (Arg1)+ M2 macrophages in vitro. Interestingly, our present study demonstrated that DTX in combination with RS significantly upregulated the mRNA expression of CXCL10 on M2 macrophages and significantly decreased the mRNA expression of CCL17 and Arg1. Moreover, the production of CXCL10 and CXCL11 from M2 macrophages was significantly increased by DTX with RS though there was no effect of DTX with RS on the production of CCL5 and CCL17. Furthermore, DTX with RS significantly decreased the production of CCL18, which was previously reported to correlate with the severity and prognosis in cancer patients. Our present report suggests one of the possible mechanisms of DTX with RS in the supportive therapy for angiosarcoma. |
| format | Article |
| id | doaj-art-fca3ecabfa964ee9ac9cf925c98c2b70 |
| institution | Kabale University |
| issn | 1740-2522 1740-2530 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Developmental Immunology |
| spelling | doaj-art-fca3ecabfa964ee9ac9cf925c98c2b702025-02-03T05:48:20ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/325412325412Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for AngiosarcomaTaku Fujimura0Yumi Kambayashi1Sadanori Furudate2Aya Kakizaki3Setsuya Aiba4Department of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, JapanAn imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response of the tumor-bearing host. We previously reported the profiles of tumor infiltrating leukocytes in cutaneous angiosarcoma (AS) and suggested that a combination of docetaxel (DTX) with bisphosphonate risedronate sodium (RS) might be effective for MMP9-expressing AS by targeting immunosuppressive cells such as M2 macrophages. To further confirm the effect of this combination therapy, in this report we investigated the immunomodulatory effect of DTX and RS on CD163+ arginase 1 (Arg1)+ M2 macrophages in vitro. Interestingly, our present study demonstrated that DTX in combination with RS significantly upregulated the mRNA expression of CXCL10 on M2 macrophages and significantly decreased the mRNA expression of CCL17 and Arg1. Moreover, the production of CXCL10 and CXCL11 from M2 macrophages was significantly increased by DTX with RS though there was no effect of DTX with RS on the production of CCL5 and CCL17. Furthermore, DTX with RS significantly decreased the production of CCL18, which was previously reported to correlate with the severity and prognosis in cancer patients. Our present report suggests one of the possible mechanisms of DTX with RS in the supportive therapy for angiosarcoma.http://dx.doi.org/10.1155/2013/325412 |
| spellingShingle | Taku Fujimura Yumi Kambayashi Sadanori Furudate Aya Kakizaki Setsuya Aiba Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma Clinical and Developmental Immunology |
| title | Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma |
| title_full | Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma |
| title_fullStr | Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma |
| title_full_unstemmed | Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma |
| title_short | Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma |
| title_sort | immunomodulatory effect of bisphosphonate risedronate sodium on cd163 arginase 1 m2 macrophages the development of a possible supportive therapy for angiosarcoma |
| url | http://dx.doi.org/10.1155/2013/325412 |
| work_keys_str_mv | AT takufujimura immunomodulatoryeffectofbisphosphonaterisedronatesodiumoncd163arginase1m2macrophagesthedevelopmentofapossiblesupportivetherapyforangiosarcoma AT yumikambayashi immunomodulatoryeffectofbisphosphonaterisedronatesodiumoncd163arginase1m2macrophagesthedevelopmentofapossiblesupportivetherapyforangiosarcoma AT sadanorifurudate immunomodulatoryeffectofbisphosphonaterisedronatesodiumoncd163arginase1m2macrophagesthedevelopmentofapossiblesupportivetherapyforangiosarcoma AT ayakakizaki immunomodulatoryeffectofbisphosphonaterisedronatesodiumoncd163arginase1m2macrophagesthedevelopmentofapossiblesupportivetherapyforangiosarcoma AT setsuyaaiba immunomodulatoryeffectofbisphosphonaterisedronatesodiumoncd163arginase1m2macrophagesthedevelopmentofapossiblesupportivetherapyforangiosarcoma |